Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas-Reference-Cited by-同舟云学术

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Published:2016-02-08 Issue:5 Volume:51 Page:654-662
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Heinzelmann F,Bethge W,Beelen D W,Engelhard M,Kröger N,Dreger P,Niederwieser D,Finke J,Bunjes D,Tischer J,Kobbe G,Holler E,Bornhäuser M,Stelljes M,Baurmann H,Müller A,Haubitz I,Schrezenmeier H,Müller C,Ottinger H

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2015348.pdf

Reference64 articles.

1. The Non-Hodgkin's Lymphoma Classification Project A. Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma. Blood 1997; 89: 3909–3918.

2. Hiddemann W, Kneba M, Dreyling M, Schmitz N, Lengfelder E, Schmits R et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 2005; 106: 3725–3732.

3. Marcus R, Imrie K, Solal-Celigny P, Catalano JV, Dmoszynska A, Raposo JC et al. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma. J Clin Oncol 2008; 26: 4579–4586.

4. Wiseman GA, Gordon LI, Multani PS, Witzig TE, Spies S, Bartlett NL et al. Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial. Blood 2002; 99: 4336–4342.

5. Kaminski MS, Tuck M, Estes J, Kolstad A, Ross CW, Zasadny K et al. 131I-tositumomab therapy as initial treatment for follicular lymphoma. N Engl J Med 2005; 352: 441–449.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups;Cancers;2022-11-18

2. Outcomes of hematopoietic cell transplantation for transformed follicular lymphoma;Hematological Oncology;2021-08-25

3. Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors;Bone Marrow Transplantation;2020-12-12

4. The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction;Frontiers in Immunology;2020-06-24

5. A multi-center retrospective analysis of patients with relapsed/refractory follicular lymphoma after third-line chemotherapy;Annals of Hematology;2020-06-12